Director/PDMR Shareholding

By

Regulatory News | 18 May, 2022

Updated : 13:05

RNS Number : 9765L
Esken Limited
18 May 2022
 

 


 

18 May 2022

Esken Limited

 

 

("Esken" or the "Company")

 

 

Director/PDMR Shareholdings

Esken, the aviation and renewable energy group, announces that Nick Dilworth, who is a Director, and Charlotte Dilworth, a person closely associated with Mr Dilworth, have sold a total of 186 Ordinary Shares (at a price per share of £0.0874) held in the name of a nominee account on their behalf to meet certain charges associated with that account. The number of shares held by Mr and Mrs Dilworth following the sale is 220,549 Ordinary Shares.

 

 

Esken Limited






Charlie Geller, Communications Director


C/O Tulchan Communications




Tulchan Communications


+44 207 353 4200




Olivia Peters / David Allchurch


esken@tulchangroup.com

 

 



 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and person closely associated with them

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Nick Dilworth

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Esken Limited

b)

LEI

213800BINQVRZFKA3E89

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each in Esken Limited

 

 

 

 

ISIN: GB00B03HDJ73

b)

Nature of the transaction

Sale of Ordinary Shares in Esken Limited to cover broker administrative charges

c)

Price(s) and

volume(s)


Shares sold by nominee at £0.0874 per share

117





d)

Aggregated information

- Aggregated volume

 

 

 

 

- Price

Price(s)

Volume(s)

£0.0874

117


e)

Date of the transaction

12 May 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Charlotte Dilworth

2

Reason for the notification

a)

Position/status

Person closely associated with Director

b)

Initial notification

/Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Esken Limited

b)

LEI

213800BINQVRZFKA3E89

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of 10 pence each in Esken Limited

 

 

 

 

ISIN: GB00B03HDJ73

b)

Nature of the transaction

Sale of Ordinary Shares in Esken Limited to cover broker administrative charges

c)

Price(s) and

volume(s)


Shares sold by nominee at £0.0874 per share

69





d)

Aggregated information

- Aggregated volume

 

 

 

 

- Price

Price(s)

Volume(s)

£0.0874

69


e)

Date of the transaction

12 May 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHEAASPFEEAEFA

Last news